Results 151 to 160 of about 7,054,284 (355)

Discussion on "Joint modeling of survival and longitudinal non-survival data" by Gould et al. [PDF]

, 2015
Bartolucci, Elashoff, Gueorguieva, Henderson, Huang, Keogh, Liu, Liu, Mauguen, Rizopoulos, Rizopoulos, Sun, Viviani   +12 more
core   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Two Centers for Species Survival launch collaborative conservation programmes

Oryx, 2023
Silvia Alvarez-Clare, Kira Mileham, Jon Paul Rodríguez, Charles R. Knapp   +3 more
doaj   +1 more source

SURVIVAL AFTER 100 YEARS OF AGE IN PORTUGUESE CENTENARIANS

, 2018
Laetitia Teixeira, Lia Araújo, Constança Paúl, Óscar Ribeiro   +3 more
openalex   +2 more sources

Tooth survival following non‐surgical root canal treatment: a systematic review of the literature [PDF]

, 2010
Y.‐L. Ng, Vera Mann, K. Gulabivala
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

November 2023 international forum on species in Haikou, China

Oryx
Yan Xie, Amaël Borzée, Kit-Yue Kwan, John MacKinnon, Haichao Zhou, Eric Ameca, Cristian Bonacic, Bo Cai, Topiltzin Contreras-MacBeath, Keith Crandall, Alok Das, Abraham Desalegn, Maximin Djondo, Weidong Li, Gregory Mueller, Serigne Sarr, Meta Sindani, Manfredo Turcios-Casco, Xinquan Zhao   +18 more
doaj   +1 more source

p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis [PDF]

, 2006
James W. Rocco, Chee‐Onn Leong, Nicolas Kuperwasser, M. Phillip DeYoung, Leif W. Ellisen   +4 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source